These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 18635698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 4. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J.
    Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
    [Abstract] [Full Text] [Related]

  • 5. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J.
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [Abstract] [Full Text] [Related]

  • 6. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC, Milani RM, Parmar R, Turner JD.
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [Abstract] [Full Text] [Related]

  • 7. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM, Parrott AC, Schifano F, Turner JJ.
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A.
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [Abstract] [Full Text] [Related]

  • 11. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 12. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
    Butler GK, Montgomery AM.
    Drug Alcohol Depend; 2004 Oct 05; 76(1):55-62. PubMed ID: 15380289
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan 05; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 19. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F, Fisk JE, Montgomery C, Bridges N.
    Cogn Behav Neurol; 2012 Sep 05; 25(3):128-38. PubMed ID: 22960437
    [Abstract] [Full Text] [Related]

  • 20. The health effects of ecstasy: a literature review.
    Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL.
    Drug Alcohol Rev; 2002 Mar 05; 21(1):53-63. PubMed ID: 12189005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.